• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    The problem with repurposing: Is there really an alternative to Big Pharma for developing new drugs for multiple sclerosis? 
    •   QMRO Home
    • Blizard Institute
    • Centre for Neuroscience, Surgery and Trauma
    • The problem with repurposing: Is there really an alternative to Big Pharma for developing new drugs for multiple sclerosis?
    •   QMRO Home
    • Blizard Institute
    • Centre for Neuroscience, Surgery and Trauma
    • The problem with repurposing: Is there really an alternative to Big Pharma for developing new drugs for multiple sclerosis?
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    The problem with repurposing: Is there really an alternative to Big Pharma for developing new drugs for multiple sclerosis?

    Volume
    4
    Pagination
    3 - 5
    DOI
    10.1016/j.msard.2014.11.005
    Journal
    MULTIPLE SCLEROSIS AND RELATED DISORDERS
    Issue
    1
    ISSN
    2211-0348
    Metadata
    Show full item record
    Authors
    Giovannonin, G; Baker, D; Schmierer, K
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/11979
    Collections
    • Centre for Neuroscience, Surgery and Trauma [993]
    Copyright statements
    © 2014 Elsevier B.V.
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.